Neogenomics People in the News: New Appointments at NeoGenomics, Mainz Biomed, IsoPlexis, More Genetron Health, NeoGenomics Partner on Oncology Drug Clinical Trials and Testing The companies will provide help with clinical drug trials and companion diagnostics projects that need a China arm for global or China-focused trials. NeoGenomics Preparing for Commercialization of Inivata MRD Test in 2022 Premium The firm's RaDaR test looks at 48 known mutations for MRD monitoring and has received breakthrough device designation from the FDA. NeoGenomics Q3 Revenues Drop 3 Percent Excluding COVID-19 revenue, the firm's revenues were up 12 percent year over year and clinical services revenue rose 11 percent. Princess Margaret Cancer Centre, Inivata Partner on Clinical Liquid Biopsy Studies Inivata's InVisionFirst-Lung and RaDaR assays will support studies of the use of liquid biopsies in early and minimal residual disease detection. Aug 6, 2021 NeoGenomics Q2 Revenues Grow 40 Percent May 7, 2021 NeoGenomics Expects Inivata Buy to Help it Penetrate MRD Monitoring Market Premium Apr 19, 2021 Amgen, NeoGenomics Partner to Expand Biomarker Testing Access in NSCLC Apr 15, 2021 Trapelo Health, Magellan Hope to Ease Prior Authorization for Precision Oncology Testing Premium Apr 8, 2021 Trapelo Health, Magellan Rx Team on Value-Based Precision Oncology Mar 24, 2021 NeoGenomics Acquires Trapelo Health in $65M Deal Mar 16, 2021 NeoGenomics, Elevation Oncology Partner on NRG1 Fusion Testing for Clinical Trial Enrollment Feb 24, 2021 NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire Feb 4, 2021 NeoGenomics, Parexel Partner to Improve Precision Oncology Trial Research Jan 22, 2021 NeoGenomics to Grow Pharma, Informatics Divisions Through CDx Agreements, Acquisitions Premium Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Jan 7, 2021 NeoGenomics Prices $500M Offering of Stock, Senior Notes Dec 11, 2020 BTIG Initiates Coverage of NeoGenomics With Buy Rating Oct 27, 2020 NeoGenomics Q3 Revenues Rise 20 Percent Sep 18, 2020 People in the News: New Appointments at Quidel, NeoGenomics, Veracyte, More Jul 28, 2020 NeoGenomics Expects Q3 Revenue Growth as it Expands Liquid Biopsy Offerings, COVID-19 Testing Premium Jul 28, 2020 NeoGenomics Q2 Revenues Fall 14 Percent Jul 2, 2020 New Products Posted to GenomeWeb: Twist Bioscience, NeoGenomics, Flagship Biosciences Jun 9, 2020 NeoGenomics, Lilly Oncology Partner for Thyroid Cancer Testing Program May 26, 2020 NeoGenomics, Inivata Partner to Commercialize Lung Cancer Liquid Biopsy Test Load More Breaking News Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease Danaher Prices $1B Offering of Senior Notes Discovery Life Sciences Acquires Contract Research Firm In Vitro ADMET Laboratories Audere Gets FDA Emergency Use Authorization for SARS-CoV-2 At-Home Sample Collection Kit GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy The Scan Science Confidence Boost The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic. Appeal and Funds Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports. Surveillance for Variants Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance. Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome In Nature this week: plant genome sequencing dominated by affluent countries, and more.